Assessment of Pain in People With Thalassemia
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Thalassemia is an inherited blood disorder that can result in mild to severe anemia. People with thalassemia often experience pain, but the exact sources and prevalence of pain remain unknown. This study will examine the prevalence and severity of pain in people with thalassemia who are treated with regular blood transfusions and people with thalassemia who are not treated with regular blood transfusions.
| Condition |
|---|
|
Thalassemia |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Assessment of Pain Survey Study |
- Prevalence of pain in participants with transfusion and non-transfusion dependent thalassemia [ Time Frame: Measured at Month 9 ] [ Designated as safety issue: No ]
- Common sites of pain by age, gender, and diagnosis [ Time Frame: Measured at Month 9 ] [ Designated as safety issue: No ]
- Pain severity and influence of age, gender, or diagnosis [ Time Frame: Measured at Month 9 ] [ Designated as safety issue: No ]
- Impact of pain on functioning and well-being [ Time Frame: Measured at Month 9 ] [ Designated as safety issue: No ]
- Effectiveness of treatment and medication over time [ Time Frame: Measured at Month 9 ] [ Designated as safety issue: No ]
- Correlate the Brief Pain Inventory (BPI) and Adolescent Pediatric Pain Tool (APPT) in the adolescent population [ Time Frame: Measured at Month 9 ] [ Designated as safety issue: No ]
| Enrollment: | 252 |
| Study Start Date: | March 2009 |
| Study Completion Date: | December 2010 |
| Primary Completion Date: | June 2010 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
1
People with transfusion-dependant thalassemia.
|
|
2
People with non-transfusion-dependant thalassemia.
|
|
3
Intermittently transfused patients- individuals who received fewer than eight transfusions in the last year
|
Detailed Description:
Thalassemia is an inherited blood disorder in which the body makes an abnormal form of hemoglobin—the protein in red blood cells that carries oxygen. People with thalassemia often experience fatigue, shortness of breath, and pain. Recent medical advances in treating people with thalassemia who receive regular blood transfusions—a standard procedure that refreshes the healthy red blood supply—have resulted in increased life spans for these people. However, with the extended life spans have come additional issues, including pain. There have been no previous research studies that have examined pain levels in people with thalassemia, and as a result, the sources and prevalence of pain remain unknown. The purpose of this study is to assess the prevalence and severity of pain, common pain sites, and the impact of pain on functioning and well-being in people with thalassemia who receive regular blood transfusions and people with thalassemia who do not receive regular blood transfusions.
This study will enroll people with transfusion-dependant thalassemia and people with non-transfusion-dependant thalassemia. At a baseline study visit, participants will complete a demographic questionnaire and a pain assessment questionnaire. At Months 3, 6, and 9, study researchers will telephone participants to go over the same pain assessment questionnaire again.
Eligibility| Ages Eligible for Study: | 12 Years to 90 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Thalassemia patients who receive regular blood transfusions and those who do not receive regular blood transfusions.
Inclusion Criteria:
Thalassemia, as documented by clinical diagnosis, including the following:
- B-thalassemia (intermedia or major)
- Hgb H disease
- Hgb H with non-deletional mutations (e.g., Hgb H Constant Spring)
- E-B-thalassemia
- Homozygous alpha thalassemia
- Other thalassemic conditions not explicitly excluded
- Thalassemia intermedia due to heterozygous B mutation with an alpha excess
- Participants can be of any race, ethnicity, and either gender.
Exclusion Criteria:
- Thalassemia trait (i.e., single recessive B gene mutation, 2 gene alpha mutation) and thalassemia Hgb S, C, or D compound heterozygotes
- Unwillingness or inability to complete the Brief Pain Inventory (BPI) on a quarterly basis
- Has had a successful bone marrow transplant
Contacts and Locations| United States, California | |
| Children's Hospital and Research Institute at Oakland | |
| Oakland, California, United States, 94609 | |
| United States, Georgia | |
| Children's Healthcare of Atlanta | |
| Atlanta, Georgia, United States, 30342 | |
| United States, Illinois | |
| Children's Memorial Hospital of Chicago | |
| Chicago, Illinois, United States, 60614 | |
| United States, Massachusetts | |
| Children's Hospital of Boston | |
| Boston, Massachusetts, United States, 02115 | |
| United States, New York | |
| Weill Medical College | |
| New York, New York, United States, 10065 | |
| United States, Pennsylvania | |
| Children's Hospital of Philadelphia | |
| Philadelphia, Pennsylvania, United States, 19104 | |
| United States, Texas | |
| Baylor College of Medicine | |
| Houston, Texas, United States, 77030 | |
| Canada, Ontario | |
| Toronto General Hospital | |
| Toronto, Ontario, Canada, M5G 2C4 | |
| Principal Investigator: | Jeanne Boudreeaux, MD | Children's Healthcare of Atlanta |
| Principal Investigator: | Ellis Neufeld, MD | Children's Hospital Boston |
| Principal Investigator: | Alexis Thompson, MD | Children's Memorial Hospital of Chicago |
| Principal Investigator: | Brigitta Mueller, MD | Baylor College of Medicine at Houston |
| Study Chair: | Dru Foote, RN, NP | Children's Hospital and Research Institute of Oakland |
| Principal Investigator: | Patricia Giardina, MD | Weill Medical College of Cornell |
| Principal Investigator: | Janet Kwiatkowski, MD | Children's Hospital of Philadelphia |
| Principal Investigator: | Nancy Olivieri, MD | Toronto General Hospital |
More Information
No publications provided
| Responsible Party: | New England Research Institutes |
| ClinicalTrials.gov Identifier: | NCT00872339 History of Changes |
| Other Study ID Numbers: | 639, U01HL065238 |
| Study First Received: | March 30, 2009 |
| Last Updated: | April 24, 2013 |
| Health Authority: | United States: Federal Government |
Keywords provided by New England Research Institutes:
|
Transfusion-Dependent Thalassemia Non-Transfusion-Dependent Thalassemia |
Additional relevant MeSH terms:
|
Thalassemia Anemia, Hemolytic, Congenital Anemia, Hemolytic Anemia |
Hematologic Diseases Hemoglobinopathies Genetic Diseases, Inborn |
ClinicalTrials.gov processed this record on May 23, 2013